trending Market Intelligence /marketintelligence/en/news-insights/trending/N9lms0nZ59bAqr_MEbTIfg2 content esgSubNav
In This List

Ultragenyx appoints independent director

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Ultragenyx appoints independent director

Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.

Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.